Sartorius Stedim Biotech header image

Sartorius Stedim Biotech

DIM

Equity

ISIN FR0013154002 / Valor 32518471

Euronext - Euronext Paris (2026-08-04)
EUR 172.90+0.58%

Sartorius Stedim Biotech
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Sartorius Stedim Biotech is a prominent global player in the biopharmaceutical industry, specializing in the development and manufacturing of biotech medications and vaccines. With a workforce of approximately 9,900 employees and operations in over 30 countries, the company provides a comprehensive range of products and technologies that support all critical stages of biopharmaceutical production and process development. Its offerings include cell line technologies, cell culture media, bioreactors, and various solutions for the separation, purification, and concentration of biological intermediates and finished products, as well as their storage and transportation. Headquartered in Aubagne, France, Sartorius Stedim Biotech is a subsidiary of Sartorius AG, which holds a significant majority of its share capital and voting rights. The company is publicly traded on the Euronext stock exchange in Paris.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

1.71%1Y
-35.9%3Y
-64.8%5Y

Performance

39.5%1Y
44.1%3Y
44.3%5Y

Volatility

Market cap

19434 M

Market cap (USD)

Daily traded volume (Shares)

74,728

Daily traded volume (Shares)

1 day high/low

187.35 / 183.25

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1111046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.32%USD 30.44
Centene Corp
Centene Corp Centene Corp Valor: 1313733
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.49%USD 64.07
Option Care Health Inc
Option Care Health Inc Option Care Health Inc Valor: 52359365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.04%USD 23.69
Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc Madrigal Pharmaceuticals Inc Valor: 33395434
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.30%USD 507.56
HealthEquity Inc
HealthEquity Inc HealthEquity Inc Valor: 24679014
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.58%USD 104.97
Ensign Group Inc
Ensign Group Inc Ensign Group Inc Valor: 3109721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.62%USD 176.13
AMN Healthcare Services Inc
AMN Healthcare Services Inc AMN Healthcare Services Inc Valor: 1269241
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.76%USD 33.25
Vijaya Diagnostic Centre Ltd.
Vijaya Diagnostic Centre Ltd. Vijaya Diagnostic Centre Ltd. Valor: 113420241
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.57%INR 1,384.15
MedPlus Health Services Ltd.
MedPlus Health Services Ltd. MedPlus Health Services Ltd. Valor: 115381597
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.82%INR 683.50
Mankind Pharma Ltd.
Mankind Pharma Ltd. Mankind Pharma Ltd. Valor: 126566338
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.54%INR 2,461.00